<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MLI-C-ARC-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Improving access to HIV and TB testing and treatment for key and at risk populations in Mali - Mali (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Mali, TB/HIV, Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </description>
    <description type="2">
      <narrative>Goals: TB : Réduire l’incidence liée au TB de 30% d’ici 2025 (par rapport à l’année 2018)/ TB: Reduce TB incidence by 30% by 2025 (compared to 2018); TB : Réduire la mortalité et la morbidité liées au TB de 50% d’ici 2025 (par rapport à l’année 2018)/ Reduce TB mortality and morbidity by 50% by 2025 (compared to 2018); VIH : Réduire l’incidence liée au VIH de 50% d’ici 2025  (par rapport à l’année 2019)/HIV: Reduce HIV-related incidence by 50% by 2025 (compared to 2019); VIH : Réduire la mortalité et la morbidité liées au VIH de 50% d’ici 2025 (par rapport à l’année 2019)/HIV: Reduce HIV-related mortality and morbidity by 50% by 2025 (compared to 2019); VIH/TB :  Les principes de droits humains et d’égalité femmes-hommes sont mis en œuvre dans le cadre du plan intégré d'ici 2023/HIV / TB: The principles of human rights and gender equality are implemented in the framework of the integrated plan by 2023; VIH/TB :  La gouvernance de la riposte nationale aux VIH, TB et hépatites virales est intégrée, efficiente et performante d’ici 2023 /HIV / TB: the governance of the national response to HIV, TB and viral hepatitis is integrated, efficient and effective by 2023. Objectives: TB : Au moins 90% des cas de TB attendus sont notifiés d’ici 2025/ TB: At least 90% of expected TB cases are notified by 2025; TB : 48% des cas attendus de TB bactériologiquement confirmés, résistants aux médicaments TB-RR et/ou TB-MR sont mis sous traitement d'ici 2023/TB: 48% of expected cases of bacteriologically confirmed TB, resistant to TB-RR drugs and / or MDR-TB are started on treatment by 2023; TB : 90% des cas de co-infection TB/VIH toutes formes (nouveaux cas + rechutes) sont traitées avec succès d'ici 2023/TB: 90% of all forms of TB / HIV co-infection (new cases + relapses) are successfully treated by 2023; VIH : En 2025, 50% des adolescent(e)s et jeunes âgés de 10 à 24 ans et des populations vulnérables disposent de compétences adaptées pour se protéger du VIH et des IST par une approche différenciée de prévention et de dépistage selon l’âge et le sexe/HIV: In 2025, 50% of adolescents and young people aged 10 to 24 and vulnerable populations have the appropriate skills to protect themselves from HIV and STIs thanks to an approach to prevention and screening differentiated by age and sex; VIH : 95% des adolescent(e)s et les femmes enceintes de 15 à 49 ans connaissent leur statut sérologique pour le VIH et bénéficient du paquet minimum de prévention VIH dès l’entrée en CPN d'ici 2023/HIV: 95% of adolescents and pregnant women aged 15 to 49 know their HIV status and benefit from the minimum HIV prevention package upon entering ANC by 2023; VIH : 95% des populations clés et vulnérables (PS, HSH, UDI et transgenre) utilisent le paquet de services de prévention combinée selon des approches différenciées d'ici 2023./HIV: 95% of key and vulnerable populations SW, MSM, IDU and transgender) use the package of combined prevention services according to a  differentiated approach by 2023; VIH : 95% des PVVIH femmes et hommes connaissant leur statut reçoivent un traitement antirétroviral/HIV: 95% of PLWHIV, both women and men, who know their status receive antiretroviral therapy; VIH/TB : D'ici 2025, l’environnement social et juridique protège les personnes touchées par le VIH/TB/HV et les populations vulnérables contre la stigmatisation et la discrimination / HIV/TB: By 2025, the social and legal environment protects people affected by HIV/TB/HIV and vulnerable populations from stigma and discrimination; VIH/TB : La coordination, le leadership, le suivi-évaluation des activités et la recherche sont assurés à travers des études pour le VIH/Sida et la Tuberculose pour l’atteinte des résultats du PSNI d'ici 2023/HIV / TB: the coordination, leadership, monitoring and evaluation of activities and research are ensured by studies on HIV / AIDS and Tuberculosis to achieve the results set by the Integrated Natinal Strategic Programme by 2023.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <other-identifier ref="MLI-C-ARCP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Saran Fadiga Ep Branchi</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>saran.branchi@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ML" percentage="100">
      <narrative>Mali</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="64.84">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="32.51">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="2.65">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="0.46">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="0.69">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="1e10e245-2f3d-48cc-8d98-b02bf369e956" percentage="1.21">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="3c4ea764-548b-44a2-9605-603566cfcdf9" percentage="2.33">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="0.61">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="c4df5dc6-61af-4f19-a9db-1c6cd15116c2" percentage="0.21">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="4.72">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e60fdd71-5159-45b8-b0e5-887e3c84eba3" percentage="0.61">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Community empowerment</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="3.42">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="d114003b-2059-4703-bbdf-e540a4be0418" percentage="3.12">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
        </description>
      </budget-item>
      <budget-item code="1eaf7f29-1761-46e4-90fd-cce9b9c1bbea" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Linkages between HIV programs and RMNCAH</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="e2860998-43fe-4145-aabf-08302069b9f1" percentage="1.89">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
        </description>
      </budget-item>
      <budget-item code="06f7d2bb-99d8-4c7b-95d2-bc02c0b90b93" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="0597f88b-5b88-4b47-8d91-6f7889b4f36f" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="56595a18-f1ed-4f39-8c05-d687d5911e6b" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="fe7b40b4-5c8d-41e2-b78b-e98fa68cabe7" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="3980356a-cb5d-41ef-9ac0-654bcf4991e7" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="2.81">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="8.99">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.3">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="61.7">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="ea41b061-34f4-4f5f-b2d7-d7e7838c9c59" percentage="0.83">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.72">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="1.65">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="0.66">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">7705185.49</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">8625326.26</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">10603778.80</value>
    </budget>
    <capital-spend percentage="4.62" />
    <transaction ref="acd26399-b975-47e3-9a48-ef40d618449c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-18" />
      <value currency="USD" value-date="2021-01-18">16661854.56</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9df605c2-bb67-4221-8f59-749f28b99f4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">2022495.69</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fabf6893-c742-4e68-b846-35e63c2a71c7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">384753.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ea5b158f-a822-4343-8b4e-4c1c24cc06fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">507337.87</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="360d0033-ad29-454e-afb7-3b7791f08cfe">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">399306.55</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="434ffea7-eea0-4b80-8e8a-8e990799e05e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">476093.01</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e12a1c0-548f-4e0b-a9f0-668c7077535f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-26" />
      <value currency="USD" value-date="2021-03-26">358815.02</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2336d374-a758-41ed-9fc0-e7ef62e55aaf">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-02" />
      <value currency="USD" value-date="2021-04-02">337164.11</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="87589e8f-0191-4122-85fd-61e84327ff0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-16" />
      <value currency="USD" value-date="2021-09-16">18766.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f4dfbb4e-6c0a-4466-8951-89a06814b99f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">1405697.13</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf17d4de-04d9-4183-abf9-2c165b235b78">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">507337.03</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83b3a986-6ba3-42a5-8bf3-18393137cc13">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">399305.93</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4773a841-7b4c-4b7d-8d01-1f65f663b8c5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">384753.58</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9644d587-8615-4c4e-a7dd-be32881d039b">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">1203667.35</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee2ffaa4-837b-42b2-9575-00c192709d6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">15975.49</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4d54f1b-577b-4ac8-8fa5-7b36f797ff19">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">245958.20</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="73f9132e-be32-4505-a0a7-3750d01878f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">301350.02</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f310d13-23aa-4607-a5e2-2e1053be8a2d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-21" />
      <value currency="USD" value-date="2021-12-21">6881.38</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db96db01-6559-40ce-9d7b-927c85e661e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">27613.83</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee4424ec-5252-4525-ba7f-c20afdbdd691">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">178195.94</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f633e58-4260-48d8-ad47-0857c1716c7e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-21" />
      <value currency="USD" value-date="2022-04-21">1263781.06</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="384e8aa1-ffcc-4994-a2e4-861e80029497">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-21" />
      <value currency="USD" value-date="2022-04-21">387403.63</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="75d8e25c-0cb6-4df7-bbdf-78760e9be381">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">631703.29</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3055ea9-54d3-4c14-92b3-1f07c4e6a2cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">254937.41</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29f0e248-3567-42af-a3af-4173ea68397b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">9967.86</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d2a3aa47-34a4-452e-a9ba-8da8cf17c529">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">1379446.78</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="45459593-9361-43e9-babf-a50f754f2521">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">64782.36</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a688d6db-717d-4b87-98b5-cfbb0250b4c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">192653.23</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e408a48f-9f9f-4b90-9745-5920144e4673">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">550114.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c5611181-3d02-4eaa-a2ee-d8b0bece4fa8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">60900.47</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8fabd331-a173-4b82-9f69-fa28b8cd9aa3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">434452.74</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9497cb56-922b-4f66-9134-1ac0f5b603fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">10896.70</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7415d9b8-79da-413d-b7b7-c01ad22a6fd7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">492137.54</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1abbe575-743b-4b2f-b274-e05953b1dfc7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">182880.66</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2fd3ad75-307d-4e1c-84a9-ae773e16598b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-29" />
      <value currency="USD" value-date="2022-09-29">349479.87</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c89d63c8-5aad-4d05-a352-f8b68110a311">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">-1214846.99</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1223b081-5f39-4189-a83e-dad2787c50de">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">5752539.46</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d016f84-8eeb-439e-8ede-efa9f69d64f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">46303.19</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="88d89663-fc05-40f4-9066-60a5edf26fde">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">535226.90</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="07e3b84d-dd22-4944-a750-7a91b92a0559">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">20157.72</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="99708fbe-b03c-4e79-adfa-82f5cad740f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-24" />
      <value currency="USD" value-date="2022-11-24">255697.35</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6bd03f6-105c-476f-b012-cd272f358b3f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-14" />
      <value currency="USD" value-date="2023-02-14">1643974.53</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="03088ee4-a39b-43a2-b0ea-30a62b3645ce">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-14" />
      <value currency="USD" value-date="2023-02-14">39634.28</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9d4fc82-92e8-4fbd-8d1f-59b23308b414">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">216598.50</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e20659f2-287a-4090-bcd7-3949daa4e5d7">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">252749.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="623812cf-7ae1-4524-a3f1-d2315b391279">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">309647.45</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c16aa02-ff1e-48b5-bff8-c750206ea63a">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">141140.36</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="65922424-3eea-4eea-b668-4f6474b3e9ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-02" />
      <value currency="USD" value-date="2023-05-02">43015.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3ecf60d4-9e88-4f38-b5ac-a263e8b84627">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-04" />
      <value currency="USD" value-date="2023-05-04">1273952.80</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15e26bc7-32e7-413a-a61d-9d625c7a6ddf">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-13" />
      <value currency="USD" value-date="2023-06-13">15280.03</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64e35fcb-90c3-4c2c-b9aa-bc64e4cc0baf">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-22" />
      <value currency="USD" value-date="2023-06-22">299042.39</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4d4a6820-d21a-4457-b292-7ea455917cda">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-13" />
      <value currency="USD" value-date="2023-07-13">-660118.03</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef8e4730-f2a0-4359-9f73-3922da31f38f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-13" />
      <value currency="USD" value-date="2023-07-13">5484678.03</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cffa6394-0e0d-4563-8199-4713c6771d53">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">22103.14</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="af37233e-8e93-4929-886a-ccbf0889fcba">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">29640.02</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31b8a620-d3de-4a6b-954e-0a40c67e5905">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">27218.47</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c81effda-5056-4c6c-b1ec-2fec213bb14b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">1620191.14</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="66b317d4-0334-4127-b546-98019add8a99">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-03" />
      <value currency="USD" value-date="2023-08-03">47533.34</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a67609c4-0e03-48d7-8660-fe255ecbacf8">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-15" />
      <value currency="USD" value-date="2023-08-15">330888.44</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d82d7e09-7314-4bb8-8c35-8ba6c241dff2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">15142.16</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e47baf1-883b-4b7c-a075-c8f8097fac1f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">309681.80</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fc610712-bad5-4eb6-ac5e-6c49904a0b88">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">49225.17</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6763ec8d-d3b2-484b-bd8a-58a8e4af314b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">1686890.84</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e9067c7f-279e-4d74-b537-65a0c6ea92f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">254179.12</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f487855c-1e7d-458a-abdd-6f472c9b7619">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-06" />
      <value currency="USD" value-date="2023-11-06">24784.97</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b015d599-de1e-44a8-9a4a-aef4f1a94a62">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-16" />
      <value currency="USD" value-date="2023-11-16">281961.21</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="13eb7eaf-f22b-4237-b3e6-c3bb848bfcbe">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-20" />
      <value currency="USD" value-date="2024-02-20">26275.85</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abbf5afc-7711-4728-995f-e40e3121c4c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-18" />
      <value currency="USD" value-date="2024-04-18">61997.46</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f23504f-9652-487d-ab4f-a7566efeba33">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-06-01" />
      <value currency="USD" value-date="2024-06-01">558.09</value>
      <description>
        <narrative>Funds returned to the Global Fund from MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="066417b8-1978-4cc5-ba80-c8447e3b4dc0">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-06-01" />
      <value currency="USD" value-date="2024-06-01">1201.31</value>
      <description>
        <narrative>Funds returned to the Global Fund from MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5671f22-aba0-499b-93a7-cacf4bdd8b43">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-07" />
      <value currency="USD" value-date="2024-06-07">-1201.31</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="134dca56-1deb-4622-823a-1cb3f22ed692">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-07" />
      <value currency="USD" value-date="2024-06-07">-558.09</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3425b34d-73bd-4933-a163-f1fd6a242f25">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-02" />
      <value currency="USD" value-date="2024-07-02">245085.76</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a382d8b-a336-4e87-b9e2-8d5b2d09f0aa">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">495916.88</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d9c8563-4bf0-4480-b927-d1181ba56a69">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-10-17" />
      <value currency="USD" value-date="2024-10-17">-451879.16</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d50924b9-ea79-4b26-a119-deb95bbd1f49">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-22" />
      <value currency="USD" value-date="2024-10-22">14422.75</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5179e30a-1e7f-4433-b5cb-3c5a9977c54d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-22" />
      <value currency="USD" value-date="2024-10-22">29836.41</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0db6cf16-7bcf-4a02-ad78-5e19872262c6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">-253903.93</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="610258b7-4d4a-4699-898c-a8e5119e3c15">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">253903.93</value>
      <description>
        <narrative>Funds returned to the Global Fund from MLI-C-ARCP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="69e1e14a-39fe-476c-938c-cd83d3ffa686">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-16" />
      <value currency="USD" value-date="2026-04-16">-451657.72</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">7704923.79</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">8527420.75</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">8655737.01</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP01-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">487115.43</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP01, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MLI-C-ARC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2020/Multicomponent/en/MLI-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Multicomponent - Mali - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR780-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2020/Multicomponent/fr/MLI-Z_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Multicomponent - Mali - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR780-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="79.97">
          <comment>
            <narrative>Numerator: 463; Denominator: 579.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="84.9">
            <comment>
              <narrative>Numerator: 880; Denominator: 1036.</narrative>
            </comment>
          </target>
          <actual value="59.2">
            <comment>
              <narrative>Numerator: 750; Denominator: 1267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="84.94">
            <comment>
              <narrative>Numerator: 440; Denominator: 518.</narrative>
            </comment>
          </target>
          <actual value="35.7">
            <comment>
              <narrative>Numerator: 185; Denominator: 518.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="84.94">
            <comment>
              <narrative>Numerator: 440; Denominator: 518.</narrative>
            </comment>
          </target>
          <actual value="75.4">
            <comment>
              <narrative>Numerator: 565; Denominator: 749.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 1030; Denominator: 1170.</narrative>
            </comment>
          </target>
          <actual value="77.4">
            <comment>
              <narrative>Numerator: 1425; Denominator: 1840.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="88.03">
            <comment>
              <narrative>Numerator: 515; Denominator: 585.</narrative>
            </comment>
          </target>
          <actual value="77">
            <comment>
              <narrative>Numerator: 681; Denominator: 884.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.03">
            <comment>
              <narrative>Numerator: 515; Denominator: 585.</narrative>
            </comment>
          </target>
          <actual value="77.8">
            <comment>
              <narrative>Numerator: 744; Denominator: 956.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.1">
            <comment>
              <narrative>Numerator: 1162; Denominator: 1290.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 1753; Denominator: 2119.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90.08">
            <comment>
              <narrative>Numerator: 581; Denominator: 645.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 870; Denominator: 1052.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.08">
            <comment>
              <narrative>Numerator: 581; Denominator: 645.</narrative>
            </comment>
          </target>
          <actual value="82.8">
            <comment>
              <narrative>Numerator: 883; Denominator: 1067.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIV initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIV initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="82.17">
          <comment>
            <narrative>Numerator: 212; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="85.8">
            <comment>
              <narrative>Numerator: 139; Denominator: 162.</narrative>
            </comment>
          </target>
          <actual value="42">
            <comment>
              <narrative>Numerator: 68; Denominator: 162.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85.8">
            <comment>
              <narrative>Numerator: 279; Denominator: 325.</narrative>
            </comment>
          </target>
          <actual value="72.4">
            <comment>
              <narrative>Numerator: 299; Denominator: 413.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85.89">
            <comment>
              <narrative>Numerator: 140; Denominator: 163.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 231; Denominator: 251.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="88.82">
            <comment>
              <narrative>Numerator: 151; Denominator: 170.</narrative>
            </comment>
          </target>
          <actual value="87.4">
            <comment>
              <narrative>Numerator: 160; Denominator: 183.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.9">
            <comment>
              <narrative>Numerator: 303; Denominator: 341.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 353; Denominator: 391.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.89">
            <comment>
              <narrative>Numerator: 152; Denominator: 171.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 193; Denominator: 208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="91.53">
            <comment>
              <narrative>Numerator: 162; Denominator: 177.</narrative>
            </comment>
          </target>
          <actual value="90.1">
            <comment>
              <narrative>Numerator: 246; Denominator: 273.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="91.5">
            <comment>
              <narrative>Numerator: 325; Denominator: 355.</narrative>
            </comment>
          </target>
          <actual value="88.1">
            <comment>
              <narrative>Numerator: 468; Denominator: 531.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="91.57">
            <comment>
              <narrative>Numerator: 163; Denominator: 178.</narrative>
            </comment>
          </target>
          <actual value="86">
            <comment>
              <narrative>Numerator: 222; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 338; Denominator: 7413; Percentage: 4.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 329.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6180; Denominator: 8267; Percentage: 74.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4587; Denominator: 8267; Percentage: 55.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5562; Denominator: 8267; Percentage: 67.28%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 546; Denominator: 8267; Percentage: 6.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 543.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6180; Denominator: 8267; Percentage: 74.76%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4587; Denominator: 8267; Percentage: 55.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5799; Denominator: 8730; Percentage: 66.43%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5460; Denominator: 8730; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6443; Denominator: 8730; Percentage: 73.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6288; Denominator: 8730; Percentage: 72%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6443; Denominator: 8730; Percentage: 73.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6288; Denominator: 8730; Percentage: 72%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 6262.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5990; Denominator: 9219; Percentage: 64.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5430; Denominator: 9219; Percentage: 58.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 5384.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6655; Denominator: 9219; Percentage: 72.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6061; Denominator: 9219; Percentage: 65.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6655; Denominator: 9219; Percentage: 72.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6061; Denominator: 9219; Percentage: 65.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 6036.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="4917" />
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="4765">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="152">
          <dimension name="HIV test status" value="Positive" />
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="4870" />
          <actual value="2621" />
          <actual value="2542">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="79">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5411" />
          <actual value="5183" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5411" />
          <actual value="5183" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5676" />
          <actual value="5839" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5449" />
          <actual value="5503" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5676" />
          <actual value="5839" />
          <actual value="5631">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="208">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5827" />
          <actual value="5911" />
          <actual value="5638">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="273">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5946" />
          <actual value="6193" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5946" />
          <actual value="6193" />
          <actual value="5935">
            <dimension name="HIV test status" value="Negative" />
          </actual>
          <actual value="258">
            <dimension name="HIV test status" value="Positive" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 8211; Denominator: 77794; Percentage: 10.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 8119.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 92.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 11581; Denominator: 25736; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4534; Denominator: 25736; Percentage: 17.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4468.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 66.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12868; Denominator: 25736; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12460; Denominator: 25736; Percentage: 48.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12868; Denominator: 25736; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12460; Denominator: 25736; Percentage: 48.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 21165; Denominator: 47033; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19073; Denominator: 47033; Percentage: 40.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23517; Denominator: 47033; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19920; Denominator: 47033; Percentage: 42.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23517; Denominator: 47033; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19920; Denominator: 47033; Percentage: 42.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 19679.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 34113; Denominator: 75805; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24733; Denominator: 75805; Percentage: 32.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 24440.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 293.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 37903; Denominator: 75805; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31827; Denominator: 75805; Percentage: 42%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 37903; Denominator: 75805; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31827; Denominator: 75805; Percentage: 42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 31434.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 393.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 846; Denominator: 2686; Percentage: 31.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 831.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 15.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1054; Denominator: 4928; Percentage: 21.39%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 949; Denominator: 4928; Percentage: 19.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 928.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1110; Denominator: 4928; Percentage: 22.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1110; Denominator: 4928; Percentage: 22.52%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1859; Denominator: 5162; Percentage: 36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2140; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1805; Denominator: 5162; Percentage: 34.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2037; Denominator: 5162; Percentage: 39.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1859; Denominator: 5162; Percentage: 36.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2140; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2098.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2242; Denominator: 5348; Percentage: 41.92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2653; Denominator: 5348; Percentage: 49.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2593.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2309; Denominator: 5348; Percentage: 43.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2878; Denominator: 5348; Percentage: 53.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2309; Denominator: 5348; Percentage: 43.18%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2878; Denominator: 5348; Percentage: 53.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2801.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 77.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 14552; Denominator: 20165; Percentage: 72.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 13970.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 582.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 15537; Denominator: 20891; Percentage: 74.37%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7770; Denominator: 20891; Percentage: 37.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 7503.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17263; Denominator: 20891; Percentage: 82.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17205; Denominator: 20891; Percentage: 82.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17263; Denominator: 20891; Percentage: 82.63%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17205; Denominator: 20891; Percentage: 82.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17619; Denominator: 21664; Percentage: 81.33%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21620; Denominator: 21664; Percentage: 99.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 19493; Denominator: 21664; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 19493; Denominator: 21664; Percentage: 89.98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 20884.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 956.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 21496; Denominator: 22422; Percentage: 95.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22634; Denominator: 22422; Percentage: 100.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 19775; Denominator: 22422; Percentage: 88.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22063; Denominator: 22422; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 21011.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1052.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 21496; Denominator: 22422; Percentage: 95.87%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22634; Denominator: 22422; Percentage: 100.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 21567.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1067.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="16.11">
          <comment>
            <narrative>Numerator: 58; Denominator: 360.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="20.98">
            <comment>
              <narrative>Numerator: 113.1; Denominator: 539.</narrative>
            </comment>
          </target>
          <actual value="15.6">
            <comment>
              <narrative>Numerator: 84; Denominator: 539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="23.3">
            <comment>
              <narrative>Numerator: 125.6; Denominator: 539.</narrative>
            </comment>
          </target>
          <actual value="37.3">
            <comment>
              <narrative>Numerator: 201; Denominator: 539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="23.3">
            <comment>
              <narrative>Numerator: 125.58; Denominator: 539.</narrative>
            </comment>
          </target>
          <actual value="37.3">
            <comment>
              <narrative>Numerator: 201; Denominator: 539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="28.94">
            <comment>
              <narrative>Numerator: 162.36; Denominator: 561.</narrative>
            </comment>
          </target>
          <actual value="36">
            <comment>
              <narrative>Numerator: 202; Denominator: 561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="32.2">
            <comment>
              <narrative>Numerator: 180.4; Denominator: 561.</narrative>
            </comment>
          </target>
          <actual value="39.2">
            <comment>
              <narrative>Numerator: 220; Denominator: 561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="32.16">
            <comment>
              <narrative>Numerator: 180.4; Denominator: 561.</narrative>
            </comment>
          </target>
          <actual value="39.2">
            <comment>
              <narrative>Numerator: 220; Denominator: 561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="37.32">
            <comment>
              <narrative>Numerator: 217.58; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="43.1">
            <comment>
              <narrative>Numerator: 251; Denominator: 582.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="41.5">
            <comment>
              <narrative>Numerator: 241.7; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="47.2">
            <comment>
              <narrative>Numerator: 275; Denominator: 583.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="41.45">
            <comment>
              <narrative>Numerator: 241.66; Denominator: 583.</narrative>
            </comment>
          </target>
          <actual value="47.2">
            <comment>
              <narrative>Numerator: 275; Denominator: 583.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="5204" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="5126" />
          <actual value="2772" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5696" />
          <actual value="5243" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="5696" />
          <actual value="5243" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="5736" />
          <actual value="5521" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5975" />
          <actual value="5839" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="5975" />
          <actual value="5839" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="6134" />
          <actual value="5966" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="6259" />
          <actual value="6195" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="6259" />
          <actual value="6195" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 950; Denominator: 2686; Percentage: 35.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 638.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 638.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 638.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 312.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 312.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 312.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 902.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 902.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 902.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1110; Denominator: 4928; Percentage: 22.52%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 968; Denominator: 4928; Percentage: 19.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 613.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 901.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1233; Denominator: 4928; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1233; Denominator: 4928; Percentage: 25.02%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1592; Denominator: 4928; Percentage: 32.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2065; Denominator: 5162; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2141; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1900; Denominator: 5162; Percentage: 36.81%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2037; Denominator: 5162; Percentage: 39.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2065; Denominator: 5162; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2141; Denominator: 5162; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1445.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 696.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 154.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1987.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2360; Denominator: 5348; Percentage: 44.13%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2654; Denominator: 5348; Percentage: 49.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1790.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 864.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 221.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2433.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2565; Denominator: 5348; Percentage: 48%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2881; Denominator: 5348; Percentage: 53.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2565; Denominator: 5348; Percentage: 47.96%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2881; Denominator: 5348; Percentage: 53.9%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="77.77">
          <comment>
            <narrative>Numerator: 15682; Denominator: 20165.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 18172; Denominator: 20891.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 17457; Denominator: 20891.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="78.29">
            <comment>
              <narrative>Numerator: 16355; Denominator: 20891.</narrative>
            </comment>
          </target>
          <actual value="37.9">
            <comment>
              <narrative>Numerator: 7921; Denominator: 20891.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="86.98">
            <comment>
              <narrative>Numerator: 18172; Denominator: 20891.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 17457; Denominator: 20891.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="93.1">
            <comment>
              <narrative>Numerator: 20159; Denominator: 21664.</narrative>
            </comment>
          </target>
          <actual value="101.5">
            <comment>
              <narrative>Numerator: 21995; Denominator: 21664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="85.61">
            <comment>
              <narrative>Numerator: 18546; Denominator: 21664.</narrative>
            </comment>
          </target>
          <actual value="100.2">
            <comment>
              <narrative>Numerator: 21704; Denominator: 21664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="93.05">
            <comment>
              <narrative>Numerator: 20159; Denominator: 21664.</narrative>
            </comment>
          </target>
          <actual value="101.5">
            <comment>
              <narrative>Numerator: 21995; Denominator: 21664.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="92.84">
            <comment>
              <narrative>Numerator: 20816; Denominator: 22422.</narrative>
            </comment>
          </target>
          <actual value="98.8">
            <comment>
              <narrative>Numerator: 22161; Denominator: 22422.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100.9">
            <comment>
              <narrative>Numerator: 22627; Denominator: 22422.</narrative>
            </comment>
          </target>
          <actual value="101.6">
            <comment>
              <narrative>Numerator: 22770; Denominator: 22422.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100.91">
            <comment>
              <narrative>Numerator: 22627; Denominator: 22422.</narrative>
            </comment>
          </target>
          <actual value="101.6">
            <comment>
              <narrative>Numerator: 22770; Denominator: 22422.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="67" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="47" />
          <actual value="24" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="94" />
          <actual value="70" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="47" />
          <actual value="46" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="118" />
          <actual value="117" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="59" />
          <actual value="45" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="59" />
          <actual value="72" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="71" />
          <actual value="71" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="142" />
          <actual value="154" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="71" />
          <actual value="83" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="532" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="532" />
          <actual value="466" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="266" />
          <actual value="76" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="266" />
          <actual value="390" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="674" />
          <actual value="922" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="337" />
          <actual value="397" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="337" />
          <actual value="525" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="904" />
          <actual value="867" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="452" />
          <actual value="414" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="452" />
          <actual value="453" />
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-MLI-C-ARC-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Improving access to HIV and TB testing and treatment for key and at risk populations in Mali - Mali (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Mali, TB/HIV, Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </description>
    <description type="2">
      <narrative>Goals: TB : Réduire l’incidence liée à la TB d'au moins 15% d’ici 2026 (par rapport à l’année 2018) /  TB: Reduce TB incidence by at least 15% by 2026 (compared to 2018); TB : Réduire la mortalité et la morbidité liées à la TB d'au moins 40% d’ici 2026 (par rapport à l’année 2018) /  TB: Reduce TB mortality and morbidity by at least 40% by 2026 (compared to 2018); VIH : Réduire les nouvelles infections liées au VIH de 60% d’ici 2026  (par rapport à l’année 2019) / HIV: Reduce new HIV infections by 60% by 2026 (compared to 2019); VIH : Réduire les décès liés au sida de 60% d’ici 2026 (par rapport à l’année 2019) /  HIV: Reduce AIDS-related deaths by 60% by 2026 (compared to 2019); VIH/TB : Les principes de droits humains et d’égalité femmes-hommes sont mis en œuvre dans le cadre du plan intégré d'ici 2026 / HIV/TB: The principles of human rights and gender equality are implemented in the framework of the integrated plan by 2026; VIH/TB : La gouvernance de la riposte nationale aux VIH, TB et hépatites virales est intégrée, efficiente et performante d’ici 2026 / HIV/TB: The governance of the national response to HIV, TB and viral hepatitis is integrated, efficient and effective by 2026; SRPS : Contribuer à l'amélioration de l'état de santé et du bien-être de la population malienne  / RSSH: Contribute to improving the health and well-being of the Malian population. Objectives: D'ici 2026, au moins 90% des cas de TB notifiés bénéficient d'un traitement de qualité et sont traités avec succès / By 2026, at least 90% of notified TB cases benefit from quality treatment and are successfully treated; D'ici 2026, au moins 85% des cas de TB-MR sont traités avec succès / By 2026, at least 85% of MDR-TB are successfully treated; En 2026, au moins 95% des populations clés (TS, HSH, UDI, personnes transgenres et détenus) et les autres populations vulnérables utilisent le paquet de services de prévention combinée selon les approches différenciées / By 2026, at least 95% of key populations (SW, MSM, PWID, transgender persons and prisoners) and other vulnerable populations are using the combined prevention service package according to differentiated approaches; D'ici 2026, l'élimination de la transmission du VIH de la mère à l'enfant est assurée à moins de 2% / By 2026, the elimination of mother-to-child transmission of HIV is ensured at less than 2%; En 2026, 95% des PVVIH connaissent leur statut sérologique pour le VIH, grâce à la mobilisation communautaire et la mise en œuvre des approches de dépistage différenciée / By 2026, 95% of PLHIV know their HIV status, thanks to community mobilization and the implementation of differentiated testing approaches; En 2026, 95% des PVVIH connaissant leur statut reçoivent un traitement antirétroviral conforme aux directives nationales, avec la contribution actives des acteurs communautaires / By 2026, 95% of PLHIV who know their status will be receiving antiretroviral treatment in line with national guidelines, with the active contribution of community players; En 2026, 100% des PVVIH ayant une coinfection TB/VIH et IO sont traités selon les directives nationales / By 2026, 100% of PLHIV with TB/HIV and OI are treated in line with national guidelines; En 2026, l'environnement social et juridique protège les PVVIH et les populations vulnérables contre la stigmatisation et la discrimination / By 2026, the social and legal environment protects people affected by HIV/TB/HIV and vulnerable populations from stigma and discrimination; Le leadership et la coordination de la riposte nationale au VIH/sida/IST/HV sont assurés efficacement au niveau central sous la direction de la CSLS-TBH en coordination avec la DGSHP, les DRS et les entités communautaires / The leadership and coordination of the national response to HIV/AIDS/STI/HV are effectively ensured at the central level under the direction of the CSLS-TBH in coordination with the DGSHP, the DRS and community entities.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
    </participating-org>
    <other-identifier ref="MLI-C-ARCP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Saran Fadiga Ep Branchi</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>saran.branchi@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ML" percentage="100">
      <narrative>Mali</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="62.19">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="32.9">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="4.91">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.73">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.63">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="1.3">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.65">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="cfd9f41e-52ee-4b8f-a55c-e416fa546878" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Community empowerment for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="8a68b0fa-0674-4039-b5d0-396ae5bcf3d3" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Removing human rights-related barriers to prevention for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="09268318-342f-41af-84e1-0aab4e2fd8f3" percentage="1.56">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d4788f0c-523b-415c-b8ec-03eaa8789e31" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="0.19">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="49ef45b6-ef30-48b1-b393-f34c25d513c4" percentage="1.4">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="10c0f677-be26-46fb-a1c0-17c238f89b7e" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Removing human rights-related barriers to prevention for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="12d964e1-5c4b-4caa-9b00-225bb89861dd" percentage="4.34">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="1.07">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0.4">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="1.4">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="c1c1a139-7603-46fe-a10f-3766fac53456" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Community empowerment for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="55ece96e-d30c-46d2-8db0-27306b249434" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.41">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="14.68">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.99">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="32.31">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="1.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="2.67">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="21.43">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="3.31">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.59">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.46">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="0.65">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcbb01c-6f63-414e-a67b-9a54f6bd04c0" percentage="0.41">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="1.08">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="2.02">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">7738193.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">9253287.63</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">7779768.35</value>
    </budget>
    <capital-spend percentage="6.03" />
    <transaction ref="37f9a1cc-17d3-477a-8566-c428624d7148">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-01" />
      <value currency="USD" value-date="2024-02-01">17853805.78</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2506121a-86d0-48f1-8230-49842244831a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-06" />
      <value currency="USD" value-date="2024-02-06">2456914.83</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10bad6f0-a50c-4a78-ac3f-d5132c224b9e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">228555.39</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6b093264-e661-4f5f-a096-b487823a9619">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">26416.37</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="78c919ae-fc2b-4f2b-ab81-9613097311eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">118797.81</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83496b9f-c0df-44be-a6ae-13f62f9adef4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">260924.99</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="892facbf-8e8d-4baa-84b8-7b4ee40f0dff">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">189195.23</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5327e85b-891c-45de-88a8-dfe1cfcf1ae6">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">218531.54</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5ce08f08-d46b-40fc-abb9-8e3ede170d2d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-25" />
      <value currency="USD" value-date="2024-06-25">139456.53</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14aa9f8d-7d5d-4a59-92aa-d1947283858c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-23" />
      <value currency="USD" value-date="2024-07-23">2507338.10</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7415ad4b-04fd-4df3-a4db-5f276369a3ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">209986.63</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="463a1363-4564-48e9-8700-13bac56caa85">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">131092.04</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cd816ac5-1870-4aaf-8250-77e44d2815b1">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-01" />
      <value currency="USD" value-date="2024-11-01">274272.44</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2feaec8-2f51-45fb-8e88-195b00ca0bd7">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-19" />
      <value currency="USD" value-date="2024-11-19">1379788.78</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4228f1cc-1716-4602-8fdd-dc345f55ee08">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-05" />
      <value currency="USD" value-date="2024-12-05">173631.55</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="565edab3-9458-4d22-9207-5018219a239b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-13" />
      <value currency="USD" value-date="2024-12-13">38153.50</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cc89f12c-ca36-41b5-885c-2b72e63060d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-19" />
      <value currency="USD" value-date="2024-12-19">47471.72</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="74fb62f7-a4ba-4308-b5f1-69b302294863">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-18" />
      <value currency="USD" value-date="2025-02-18">359714.38</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f77e7f2-133c-4876-a8be-568ba3ad45b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">993836.67</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9c637356-e2d6-4eb9-b8b3-ec4ef91a356d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-04" />
      <value currency="USD" value-date="2025-03-04">191181.07</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c787a3a-bf25-4ac6-b8b1-6f8423b51cc2">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">159026.33</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e2e65d9-bb14-4b3a-8db0-c52591948c19">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">207476.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1fe2a776-20eb-4964-8db2-548f36d0e256">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">147650.77</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47393cce-2a2a-45d7-bc1a-b48b5b81ac0d">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">193687.59</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3a07276d-bcd0-4f39-b418-c2e20bdd7b0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-27" />
      <value currency="USD" value-date="2025-03-27">158690.85</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ada6e53-967c-4ebc-a16e-0d7d914df9ae">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-17" />
      <value currency="USD" value-date="2025-04-17">183392.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e2c794c2-86ff-43e2-b71c-dfa1d91f4f82">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-13" />
      <value currency="USD" value-date="2025-05-13">1393234.73</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2775a34e-e586-4cf5-8ecc-2ad82b54d147">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">373397.15</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3961d372-1716-4a4a-b40e-7eabb2acf9bd">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">72758.31</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9122433a-539c-4b00-8813-a48e1cc9d9df">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">1163444.98</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3ff374d2-ff53-4846-b0a1-706e8a29ed20">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">24187.20</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="be3d1b01-14e0-4f7d-b561-7a9bfdc18e3b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">2501666.36</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dd8f494e-8422-4e20-b955-c1c093f980a2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-22" />
      <value currency="USD" value-date="2025-10-22">-3831598.36</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a485cc3f-ac32-4cf4-911b-9a6462decb3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">1428863.58</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0d818dd8-2513-433e-9b1f-3d78bf39847b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">159277.69</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f0bac82-5e50-4b54-b8cf-ccdd6f6eaf30">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">74338.73</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a0b30441-dadb-4e23-91ea-d7728489f7da">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">51003.46</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="889fb44c-46df-40a6-b957-eac2416266f7">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">130407.03</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="345e9b8a-f9ea-43a3-a4e8-6d256858d13f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">38496.12</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15cfd476-06ed-4486-a2d7-1e3200db75ad">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">228715.35</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d716008c-07cb-427e-b4f1-ac079805af5c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">228715.35</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3632793-cded-4384-b9bf-440ccb92dc94">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">70214.15</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="30eaf5af-84c4-4c47-8628-4da0df52f2a2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-09" />
      <value currency="USD" value-date="2026-02-09">-549065.60</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5685c504-54d3-481f-bf99-961e2686ff01">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-09" />
      <value currency="USD" value-date="2026-02-09">3675155.57</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b1906bd6-d8e4-4c93-9142-1de802e40a3e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">3126089.97</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0bfddfa1-23a0-4244-87b7-addcb48923bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-24" />
      <value currency="USD" value-date="2026-04-24">5441636.38</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="19414aef-81a3-4dfd-be4a-10a1752c0ae8">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-24" />
      <value currency="USD" value-date="2026-04-24">-549065.60</value>
      <description>
        <narrative>Global Fund commitment to MLI-C-ARCP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc4cbf3f-3cee-4488-a9fc-d47cea69dc27">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">155311.48</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d804d464-0fa0-4d46-90ea-0ede0e7e671d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">180866.70</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="da512498-8f21-4e47-a06d-b7fa3ff6f7a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">137338.05</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dab0471e-4a7a-4979-8937-4764157aa1e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">70138.95</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e27bad2a-4ba2-44b0-bb5b-c33de18ab32b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">159254.75</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a4b0ed13-2cd3-4617-8b06-ec38154cbe0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">186846.70</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94949162-9b1a-48ae-89c9-aedeb1e541ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">163943.96</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="611b28fe-4769-4cda-982f-e650ac3f1603">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">3317939.23</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f5a5220e-39bc-4910-a0f7-e574d284c920">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-18" />
      <value currency="USD" value-date="2026-08-18">143201.10</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f508c95a-81fb-4381-b136-83bf21dfe5bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-15" />
      <value currency="USD" value-date="2026-09-15">17398.04</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="992fce14-afa7-4929-ae63-588e761d5e8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-15" />
      <value currency="USD" value-date="2026-09-15">58985.89</value>
      <description>
        <narrative>Global Fund disbursement to MLI-C-ARCP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="MLI-C-ARCP02-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">7738193.82</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP02, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <transaction ref="MLI-C-ARCP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">8016943.32</value>
      <description>
        <narrative>Expenditure reported by Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus for MLI-C-ARCP02, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Association pour la Résilience des Communautés vers l’Accès au Développement et à la Santé Plus</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/MLI-C-ARC" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2023/Multicomponent/en/MLI-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - Multicomponent - Mali - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1506-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/MLI/2023/Multicomponent/fr/MLI-Z_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - Multicomponent - Mali - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1506-MLI-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="3">
        <narrative>3 - (1) Grant Funds may be used to pay for services performed by a fiscal agent retained by the Global Fund (the “Fiscal Agent”) and the Global Fund may disburse such Grant Funds directly to the Fiscal Agent; (2) The Principal Recipient consents to the terms of reference of the Fiscal Agent and agrees that such terms of reference may be amended from time to time at the Global Fund’s discretion; (3) The Principal Recipient shall cooperate fully with the Fiscal Agent to allow the Fiscal Agent to perform its services, including, but not limited to, by (a) providing all information requested by the Fiscal Agent or the Global Fund; (b) taking all necessary actions prior to collection of Personal Data and at all times thereafter to ensure that the processing of Personal Data by the Fiscal Agent does not violate any applicable law or regulation; and (c) implementing any recommendations made by the Fiscal Agent; and (4) The appointment of the Fiscal Agent shall not, nor shall it be construed to, discharge the Principal Recipient of their respective obligations under the Grant Agreement, which shall remain in full force and effect. The Fiscal Agent shall not have authority to act as the Global Fund’s agent, unless provided otherwise in writing by the Global Fund. Accordingly, the Global Fund reserves the right to classify any expenditure of Grant Funds as non-compliant, notwithstanding its verification or endorsement by the Fiscal Agent.</narrative>
      </condition>
      <condition type="3">
        <narrative>4 - (1) Grant Funds may be used to pay for the services of an external auditor retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; (2) the Principal Recipient consents to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2024-2026 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing), and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund.</narrative>
      </condition>
      <condition type="1">
        <narrative>5 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of EUR 12,141,560 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.5(1)(a) and 5.5(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) maintain government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in Commitment Letter, dated 27 October 2023 (the “Commitment Letter”)], unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of EUR 305,557,965 from 2024-2026 (inclusive), comprising investments in: i. the budget-program “Multisectoral HIV Program” of EUR 8,262,003; ii. the budget program “Primary Health Care and Disease Control” of EUR 252,009,108; iii. the budget program “Availability of Medicines, Vaccines and Consumables and Financial Accessibility to Health Care and Participation” of EUR 45,286,854; and (b) provide to the Global Fund, by no later than 31 October of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for the three budget-programs for the upcoming year; and ii. the total expenditure for the three budget-programs in the previous fiscal year.</narrative>
      </condition>
      <condition type="2">
        <narrative>6 - The Principal Recipient acknowledges the obligation to repay to the Global Fund the total amount of EUR 1,598.18, which the Global Fund has determined as recoverable pursuant to the terms of the relevant grant agreements and comprised of: a. EUR 506 arising from financial reviews, as communicated to the Principal Recipient through the demand letter dated 1 November 2023. b. EUR 1,098.18 arising from financial reviews, as communicated to the Principal Recipient through the demand letter dated 11 October 2023.</narrative>
      </condition>
      <condition type="2">
        <narrative>7 - Banking Services Prior to the implementation and use of Grant Funds by the Principal Recipient, the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s written approval of, evidence of a competitive process and selection for banking services which will be used by the Principal Recipient for the safeguarding of Grant Funds. The selection of banking services should take into consideration the safeguarding of funds, the conditions of services, the geographic coverage of the banking services provider and compliance with the terms and conditions of the Grant Agreement.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV who were initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other1 Percentage of sex workers newly diagnosed with HIV who were initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="77.56">
          <comment>
            <narrative>Numerator: 1434; Denominator: 1849.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95.05">
            <comment>
              <narrative>Numerator: 749; Denominator: 788.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1498; Denominator: 1577.</narrative>
            </comment>
          </target>
          <actual value="93.89">
            <comment>
              <narrative>Numerator: 2058; Denominator: 2192.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="94.93">
            <comment>
              <narrative>Numerator: 749; Denominator: 789.</narrative>
            </comment>
          </target>
          <actual value="97.12">
            <comment>
              <narrative>Numerator: 1080; Denominator: 1112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 781; Denominator: 822.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1563; Denominator: 1645.</narrative>
            </comment>
          </target>
          <actual value="97.31">
            <comment>
              <narrative>Numerator: 1914; Denominator: 1967.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 782; Denominator: 823.</narrative>
            </comment>
          </target>
          <actual value="99.55">
            <comment>
              <narrative>Numerator: 1100; Denominator: 1105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95.05">
            <comment>
              <narrative>Numerator: 807; Denominator: 849.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="94.94">
            <comment>
              <narrative>Numerator: 807; Denominator: 850.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIVwho were initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-5-Other2 Percentage of MSM newly diagnosed with HIVwho were initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="90.28">
          <comment>
            <narrative>Numerator: 353; Denominator: 391.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95.1">
            <comment>
              <narrative>Numerator: 504; Denominator: 530.</narrative>
            </comment>
          </target>
          <actual value="89.94">
            <comment>
              <narrative>Numerator: 590; Denominator: 656.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95.09">
            <comment>
              <narrative>Numerator: 252; Denominator: 265.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95.09">
            <comment>
              <narrative>Numerator: 252; Denominator: 265.</narrative>
            </comment>
          </target>
          <actual value="94.43">
            <comment>
              <narrative>Numerator: 322; Denominator: 341.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95.05">
            <comment>
              <narrative>Numerator: 288; Denominator: 303.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.1">
            <comment>
              <narrative>Numerator: 577; Denominator: 607.</narrative>
            </comment>
          </target>
          <actual value="96.35">
            <comment>
              <narrative>Numerator: 422; Denominator: 438.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.07">
            <comment>
              <narrative>Numerator: 289; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="102.17">
            <comment>
              <narrative>Numerator: 235; Denominator: 230.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95.06">
            <comment>
              <narrative>Numerator: 327; Denominator: 344.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="94.78">
            <comment>
              <narrative>Numerator: 327; Denominator: 345.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 5839; Denominator: 11379; Percentage: 51.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7572; Denominator: 12142; Percentage: 62.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7367; Denominator: 12142; Percentage: 60.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7139; Denominator: 12142; Percentage: 58.8%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7572; Denominator: 12142; Percentage: 62.36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7367; Denominator: 12142; Percentage: 60.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 380.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 2085.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 4902.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8123; Denominator: 12543; Percentage: 64.76%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8674; Denominator: 12543; Percentage: 69.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7178; Denominator: 12543; Percentage: 57.23%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8674; Denominator: 12543; Percentage: 69.15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7178; Denominator: 12543; Percentage: 57.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 368.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1575.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5235.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9258; Denominator: 12957; Percentage: 71.45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9841; Denominator: 12957; Percentage: 75.95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 220; Denominator: 428; Percentage: 51.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 20.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 104.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 104.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 96.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 96.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 262; Denominator: 457; Percentage: 57.33%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 292; Denominator: 457; Percentage: 63.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 305; Denominator: 457; Percentage: 66.74%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 292; Denominator: 457; Percentage: 63.89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 305; Denominator: 457; Percentage: 66.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 186.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 107.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 309; Denominator: 472; Percentage: 65.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 310; Denominator: 472; Percentage: 65.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 294; Denominator: 472; Percentage: 62.29%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 309; Denominator: 472; Percentage: 65.47%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 310; Denominator: 472; Percentage: 65.68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 173.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 314; Denominator: 487; Percentage: 64.48%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 331; Denominator: 487; Percentage: 67.97%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2140; Denominator: 6952; Percentage: 30.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1442.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1442.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1994.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1994.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2538; Denominator: 7419; Percentage: 34.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2671; Denominator: 7419; Percentage: 36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3269; Denominator: 7419; Percentage: 44.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2671; Denominator: 7419; Percentage: 36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3269; Denominator: 7419; Percentage: 44.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 218.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1038.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2013.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 446.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2823.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3004; Denominator: 7664; Percentage: 39.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3166; Denominator: 7664; Percentage: 41.31%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2838; Denominator: 7664; Percentage: 37.03%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3004; Denominator: 7664; Percentage: 39.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3166; Denominator: 7664; Percentage: 41.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 177.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 835.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2154.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 399.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2767.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3170; Denominator: 7917; Percentage: 40.04%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3335; Denominator: 7917; Percentage: 42.12%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 21850; Denominator: 23651; Percentage: 92.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2194.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2194.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7560.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7560.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12086.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12086.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.81%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21840; Denominator: 21664; Percentage: 100.81%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 22523; Denominator: 25230; Percentage: 89.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23873; Denominator: 25230; Percentage: 94.62%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 22355; Denominator: 25230; Percentage: 88.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 22523; Denominator: 25230; Percentage: 89.27%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23873; Denominator: 25230; Percentage: 94.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1890.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 8702.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 13228.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 23873.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23507; Denominator: 26062; Percentage: 90.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24958; Denominator: 26062; Percentage: 95.76%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 23015; Denominator: 26062; Percentage: 88.31%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23507; Denominator: 26062; Percentage: 90.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24958; Denominator: 26062; Percentage: 95.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1897.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 7878.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 15183.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 24958.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 23892; Denominator: 26922; Percentage: 88.75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24276; Denominator: 26922; Percentage: 90.17%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="122" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="174" />
          <actual value="223" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="87" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="87" />
          <actual value="108" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="115" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="230" />
          <actual value="216" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="115" />
          <actual value="113" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="146" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="146" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 5839; Denominator: 11379; Percentage: 51.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 422.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 2166.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 3251.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7971; Denominator: 12142; Percentage: 65.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3810; Denominator: 12142; Percentage: 31.38%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7971; Denominator: 12142; Percentage: 65.65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3810; Denominator: 12142; Percentage: 31.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 225.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1018.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2567.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8551; Denominator: 12543; Percentage: 68.17%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9131; Denominator: 12543; Percentage: 72.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7187; Denominator: 12543; Percentage: 57.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9131; Denominator: 12543; Percentage: 72.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7187; Denominator: 12543; Percentage: 57.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 372.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1581.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5234.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9745; Denominator: 12957; Percentage: 75.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10359; Denominator: 12957; Percentage: 79.95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2141; Denominator: 6952; Percentage: 30.8%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 528.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1443.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1443.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 146.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1995.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1995.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2811; Denominator: 7419; Percentage: 37.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1605; Denominator: 7419; Percentage: 21.63%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2811; Denominator: 7419; Percentage: 37.89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1605; Denominator: 7419; Percentage: 21.63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 103.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 450.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1052.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 193.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1412.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3162; Denominator: 7664; Percentage: 41.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2865; Denominator: 7664; Percentage: 37.38%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2987; Denominator: 7664; Percentage: 38.97%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3162; Denominator: 7664; Percentage: 41.26%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2865; Denominator: 7664; Percentage: 37.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 156.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 764.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1918.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 364.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2501.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3342; Denominator: 7917; Percentage: 42.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3532; Denominator: 7917; Percentage: 44.61%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 21995; Denominator: 23651; Percentage: 93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2207.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 2207.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7613.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 7613.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12175.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 12175.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21995; Denominator: 21664; Percentage: 101.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21995; Denominator: 21664; Percentage: 101.53%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23709; Denominator: 25230; Percentage: 94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4459; Denominator: 25230; Percentage: 17.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 23709; Denominator: 25230; Percentage: 93.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4459; Denominator: 25230; Percentage: 17.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 517.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 1599.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2343.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4459.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 24227; Denominator: 26062; Percentage: 92.96%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24744; Denominator: 26062; Percentage: 94.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25094; Denominator: 26062; Percentage: 96.29%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24744; Denominator: 26062; Percentage: 94.94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25094; Denominator: 26062; Percentage: 96.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1903.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 7911.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 15280.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 25094.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 25149; Denominator: 26922; Percentage: 93.41%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 25554; Denominator: 26922; Percentage: 94.92%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="14.73">
          <comment>
            <narrative>Numerator: 1163; Denominator: 7897.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="20.01">
            <comment>
              <narrative>Numerator: 871; Denominator: 4353.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="20">
            <comment>
              <narrative>Numerator: 1742; Denominator: 8706.</narrative>
            </comment>
          </target>
          <actual value="18.42">
            <comment>
              <narrative>Numerator: 1176; Denominator: 6386.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="20.01">
            <comment>
              <narrative>Numerator: 871; Denominator: 4353.</narrative>
            </comment>
          </target>
          <actual value="23.02">
            <comment>
              <narrative>Numerator: 739; Denominator: 3210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 2296; Denominator: 9185.</narrative>
            </comment>
          </target>
          <actual value="26.57">
            <comment>
              <narrative>Numerator: 1662; Denominator: 6256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 1148; Denominator: 4592.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="24.99">
            <comment>
              <narrative>Numerator: 1148; Denominator: 4593.</narrative>
            </comment>
          </target>
          <actual value="27.49">
            <comment>
              <narrative>Numerator: 862; Denominator: 3136.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="24.99">
            <comment>
              <narrative>Numerator: 1211; Denominator: 4845.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="24.99">
            <comment>
              <narrative>Numerator: 1211; Denominator: 4845.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>